Funding Details
- Awarder
- Inbox
- Date Award
- December 27, 2024
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
Company Info
- Founders
- Dr. Guofeng Cheng
- Company Description
- AusperBio is a clinical-stage biopharmaceutical company dedicated to advancing oligonucleotide and targeted delivery technologies for transformative therapies, with an initial focus on curing chronic hepatitis B infection. The company has developed a proprietary Med-Oligo™ ASO platform which has been shown to substantially enhance the current ASO therapeutics, through novel insights into ASO design.
- Market
- Chronic hepatitis B infection treatment
- Location
-
San Mateo,
California,
USA
- Coinvestors
- CDH Investments, HanKang Capital, InnoPinnacle Fund, Qiming Venture Partners, Sherpa Capital, YuanBio Venture Capital
Links